deca durabolin
aspen pharma trading limited - nandrolone - nandrolone
deca-durabolin 50 mg soluzione iniettabile (i. m.)
aspen pharma schweiz gmbh - nandroloni decanoas - soluzione iniettabile (i. m.) - nandroloni decanoas 50 mg, conserv.: alcohol benzylicus 0.1 ml, arachidis oleum raffinatum q.s. ad solutionem pro 1 ml. - provata l'osteoporosi nelle donne in postmenopausa - synthetika
deca butir integratore alimentare 30 compresse
deca laboratorio chimico srl -
deca decagin integratore alimentare 15 compresse
deca laboratorio chimico srl -
deca rinostil wash doccia nasale
deca laboratorio chimico srl -
deca nausil idra integratore alimentare 12 bustine
deca laboratorio chimico srl -
deca sedo calcio plus per aerosol 100ml
deca laboratorio chimico srl -
deca-durabolin 50 mg injektionslösung (i.m.)
deca-durabolin 50 mg solution injectable (i. m.)
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agenti antineoplastici - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.